ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

HEMO Hemogenyx Pharmaceuticals Plc

1.76
-0.0025 (-0.14%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hemogenyx Pharmaceuticals Plc LSE:HEMO London Ordinary Share GB00BYX3WZ24 ORD GBP0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.0025 -0.14% 1.76 1.73 1.76 1.75 1.73 1.74 7,822,292 16:35:08
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Finance Services 0 -3.98M -0.0035 -4.97 19.87M

Hemogenyx Pharmaceuticals PLC Second Price Monitoring Extn (6694Y)

10/09/2020 4:40pm

UK Regulatory


Hemogenyx Pharmaceuticals (LSE:HEMO)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Hemogenyx Pharmaceuticals Charts.

TIDMHEMO

RNS Number : 6694Y

Hemogenyx Pharmaceuticals PLC

10 September 2020

Second Price Monitoring Extension

A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes.

Following the first price monitoring extension this security would still have executed more than a pre-determined percentage above or below the price of the most recent automated execution today. London Stock Exchange electronic order book users have a final opportunity to review the prices and sizes of orders entered in this security prior to the auction execution.

The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

APMGPUUCBUPUGAU

(END) Dow Jones Newswires

September 10, 2020 11:40 ET (15:40 GMT)

1 Year Hemogenyx Pharmaceuticals Chart

1 Year Hemogenyx Pharmaceuticals Chart

1 Month Hemogenyx Pharmaceuticals Chart

1 Month Hemogenyx Pharmaceuticals Chart

Your Recent History

Delayed Upgrade Clock